NGC Update Service: November 18, 2013

National Guideline Clearinghouse (NGC)

November 18, 2013


New This Week

Guideline Summaries

American Urological Association Education and Research, Inc.

Canadian Cardiovascular Society

European Association of Urology

University of New South Wales New Developer

Announcements

NGC Spotlight

See the updated Mobile Device Resources page for information on the availability of full-text guidelines and/or companion documents available in downloadable versions for smart phones and hand-held devices.

Revised Inclusion Criteria

NGC has revised its Inclusion Criteria! Visit our updated Inclusion Criteria page to see the new criteria and send us your comments.

Health Awareness Topics - November 2013

Conference News

  • The Guidelines International Network North America (G-I-N NA) continues to sponsor a monthly webinar series on topics of interest to the North American guideline community. Information on upcoming webinars, as well as audio files and slides from past webinars, is available on the G-I-N Web site.

U.S. Food and Drug Administration (FDA) Advisory

  • November 6, 2013: Low Molecular Weight Heparins: FDA is recommending that health care professionals carefully consider the timing of spinal catheter placement and removal in patients taking anticoagulant drugs, such as enoxaparin, and delay dosing of anticoagulant medications for some time interval after catheter removal to decrease the risk of spinal column bleeding and subsequent paralysis after spinal injections, including epidural procedures and lumbar punctures. These new timing recommendations, which can decrease the risk of epidural or spinal hematoma, will be added to the labels of anticoagulant drugs known as low molecular weight heparins, including Lovenox and generic enoxaparin products and similar products.

NGC's Sister Resources